XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023   32,023,004      
Beginning balance at Dec. 31, 2023 $ 1,233,397 $ 32 $ 736,191 $ 495,383 $ 1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,699     11,699  
Unrealized loss on investment, net of tax (442)       (442)
Stock-based compensation 1,529   1,538 (9)  
Issuance of restricted and deferred stock units (in shares)   30,432      
Issuance of restricted and deferred stock units (1,215)   (1,215)    
Employee stock purchase plan (in shares)   21,755      
Employee stock purchase plan 1,101   1,101    
Common stock issuance, net of costs (in shares)   126,025      
Common stock issuance, net of costs 7,006   7,006    
Dividends paid (12,824)     (12,824)  
Ending balance (in shares) at Mar. 31, 2024   32,201,216      
Ending balance at Mar. 31, 2024 1,240,251 $ 32 744,621 494,249 1,349
Beginning balance (in shares) at Dec. 31, 2023   32,023,004      
Beginning balance at Dec. 31, 2023 1,233,397 $ 32 736,191 495,383 1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 71,047        
Ending balance (in shares) at Sep. 30, 2024   33,226,735      
Ending balance at Sep. 30, 2024 1,333,805 $ 33 804,848 527,575 1,349
Beginning balance (in shares) at Mar. 31, 2024   32,201,216      
Beginning balance at Mar. 31, 2024 1,240,251 $ 32 744,621 494,249 1,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 20,696     20,696  
Stock-based compensation 1,267   1,275 (8)  
Issuance of restricted and deferred stock units (in shares)   9,083      
Issuance of restricted and deferred stock units (2)   (2)    
Common stock issuance, net of costs (in shares)   458,605      
Common stock issuance, net of costs 25,296 $ 1 25,295    
Dividends paid (12,900)     (12,900)  
Ending balance (in shares) at Jun. 30, 2024   32,668,904      
Ending balance at Jun. 30, 2024 1,274,608 $ 33 771,189 502,037 1,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 38,652     38,652  
Stock-based compensation 1,558   1,566 (8)  
Issuance of restricted and deferred stock units (in shares)   1,388      
Issuance of restricted and deferred stock units (1)   (1)    
Employee stock purchase plan (in shares)   21,098      
Employee stock purchase plan 1,087   1,087    
Common stock issuance, net of costs (in shares)   535,345      
Common stock issuance, net of costs 31,007   31,007    
Dividends paid (13,106)     (13,106)  
Ending balance (in shares) at Sep. 30, 2024   33,226,735      
Ending balance at Sep. 30, 2024 $ 1,333,805 $ 33 804,848 527,575 1,349
Beginning balance (in shares) at Dec. 31, 2024 33,629,169 33,629,169      
Beginning balance at Dec. 31, 2024 $ 1,366,974 $ 34 827,796 537,184 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 16,551     16,551  
Stock-based compensation 1,201   1,210 (9)  
Issuance of restricted and deferred stock units (in shares)   31,587      
Issuance of restricted and deferred stock units (908)   (908)    
Employee stock purchase plan (in shares)   26,129      
Employee stock purchase plan 1,116   1,116    
Common stock issuance, net of costs (in shares)   495,900      
Common stock issuance, net of costs 26,545   26,545    
Dividends paid (14,142)     (14,142)  
Ending balance (in shares) at Mar. 31, 2025   34,182,785      
Ending balance at Mar. 31, 2025 $ 1,397,337 $ 34 855,759 539,584 1,960
Beginning balance (in shares) at Dec. 31, 2024 33,629,169 33,629,169      
Beginning balance at Dec. 31, 2024 $ 1,366,974 $ 34 827,796 537,184 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 86,358        
Ending balance (in shares) at Sep. 30, 2025 35,805,089 35,805,089      
Ending balance at Sep. 30, 2025 $ 1,523,663 $ 36 941,759 579,908 1,960
Beginning balance (in shares) at Mar. 31, 2025   34,182,785      
Beginning balance at Mar. 31, 2025 1,397,337 $ 34 855,759 539,584 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 24,675     24,675  
Stock-based compensation 1,455   1,464 (9)  
Issuance of restricted and deferred stock units (in shares)   16,702      
Issuance of restricted and deferred stock units (61)   (61)    
Common stock issuance, net of costs (in shares)   1,087,593      
Common stock issuance, net of costs 57,169 $ 1 57,168    
Dividends paid (14,604)     (14,604)  
Ending balance (in shares) at Jun. 30, 2025   35,287,080      
Ending balance at Jun. 30, 2025 1,465,971 $ 35 914,330 549,646 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 45,132     45,132  
Stock-based compensation 1,979   1,988 (9)  
Issuance of restricted and deferred stock units (in shares)   418      
Issuance of restricted and deferred stock units 1   1    
Employee stock purchase plan (in shares)   24,732      
Employee stock purchase plan 1,015   1,015    
Common stock issuance, net of costs (in shares)   492,859      
Common stock issuance, net of costs 24,426 $ 1 24,425    
Dividends paid $ (14,861)     (14,861)  
Ending balance (in shares) at Sep. 30, 2025 35,805,089 35,805,089      
Ending balance at Sep. 30, 2025 $ 1,523,663 $ 36 $ 941,759 $ 579,908 $ 1,960